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Abstract Endogenous retroviral sequences provide a molecular fossil record of ancient
infections whose analysis might illuminate mechanisms of viral extinction. A close relative of
gammaretroviruses, HERV-T, circulated in primates for ~25 million years (MY) before apparent
extinction within the past ~8 MY. Construction of a near-complete catalog of HERV-T fossils in
primate genomes allowed us to estimate a ~32 MY old ancestral sequence and reconstruct a
functional envelope protein (ancHTenv) that could support infection of a pseudotyped modern
gammaretrovirus. Using ancHTenv, we identify monocarboxylate transporter-1 (MCT-1) as a
receptor used by HERV-T for attachment and infection. A single HERV-T provirus in hominid
genomes includes an env gene (hsaHTenv) that has been uniquely preserved. This apparently
exapted HERV-T env could not support virion infection but could block ancHTenv mediated
infection, by causing MCT-1 depletion from cell surfaces. Thus, hsaHTenv may have contributed to
HERV-T extinction, and could also potentially regulate cellular metabolism.
DOI: 10.7554/eLife.22519.001
Introduction
When the targets of a given retrovirus include host cells that will become part of the germ-line, viral
sequences can become inherited and sometimes fixed in host populations. Indeed, about 8% of the
human genome is composed of inactive or fragmented endogenous retroviruses (ERVs)
(Lander et al., 2001). A few retroviral genes and regulatory DNA elements have been exapted to
perform diverse host functions, such as syncytial trophoblast fusion (Lavialle et al., 2013), and tran-
scriptional regulation (Chuong et al., 2016; Fort et al., 2014; Lu et al., 2014; Macfarlan et al.,
2012; Rebollo et al., 2012; Ting et al., 1992). In particular, a number of endogenous viral elements
have been shown to exhibit antiviral activity. Indeed, gag (Best et al., 1996; Murcia et al., 2007;
Yan et al., 2009), env (Gardner et al., 1991; Ito et al., 2013; Kozak, 2015; McDougall et al.,
1994; Robinson and Lamoreux, 1976; Spencer et al., 2003), and accessory genes
(Czarneski et al., 2003; Frankel et al., 1991) from endogenous viruses have been shown to contrib-
ute to host defense against exogenous retroviruses, through a variety of mechanisms.
Although some functions have been ascribed to exapted retroviral fragments, most provide no
obvious advantage to their host. Nonetheless, endogenous proviruses represent a fossil record of
past infections, enabling the study of ‘paleovirology’ (Emerman and Malik, 2010). In particular, the
synthesis of consensus or deduced ancestral sequences based on retroviral fossils has enabled the
functional analyses of reconstructed proteins from ancient, presumptively extinct, retroviruses
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(Dewannieux et al., 2006; Goldstone et al., 2010; Kaiser et al., 2007; Lee and Bieniasz, 2007;
Perez-Caballero et al., 2008; Soll et al., 2010).
Numerous members of the gammaretrovirus genus currently circulate in mammalian species, but
exogenous gammaretroviruses appear absent from modern humans (Be´nit et al., 2001). A key ques-
tion in virology, that is potentially answerable using paleovirological analyses, is what caused the
elimination of extinct viral lineages? Here, we address this question for an extinct lineage of gam-
maretroviruses that replicated in ancient primates (HERV-T) (Blusch et al., 1997). While no functional
HERV-T genes have been found in available modern primate genomes, we show that a single
HERV-T env gene was apparently exapted in hominids. We find that the product of this HERV-T env
gene can block retroviral infection mediated by a reconstructed, functional ancestral HERV-T env, by
depleting the HERV-T receptor from cell surfaces. Thus, this exapted env gene may have driven the
extinction of HERV-T from hominids.
Results
Using similarity search-based approaches, we constructed a comprehensive catalog of HERV-T fossils
in old world monkey (OWM) and ape genomes (Figure 1—source data 1). Phylogenetic analysis of
near-complete proviral elements revealed three major HERV-T clades (T1–T3), each of which was
associated with phylogenetically distinct LTR sequences, (Figure 1—figure supplement 1A). Two
clades (HERV-T3 and HERV-T2) were previously annotated (LTR6A and LTR6B in RepBase
[Bao et al., 2015]) while a third (HERV-T1) was novel. Other HERV-T-like sequences (found by simi-
larity to HERV-T protein-coding genes) are present in new world monkeys (platyrrhini primates) and
documented in Repbase (Bao et al., 2015). The presence of orthologous HERV-T loci in various pri-
mate species, and integration dates estimated from LTR divergence (Figure 1—source data 1), indi-
cated that the infectious ancestor of HERV-T entered primate germlines between ~43 and ~32 MY
ago (MYA). Additional germline integration events occurred in various primate lineages for the
eLife digest Over millions of years, viruses and the animals that they infect have been locked in
a battle for survival, where each has needed to evolve ways to counteract the effects of the other.
While the evolution of ancient animals can be studied by looking at the fossilized remains of their
extinct relatives, studying how ancient viruses have evolved is more difficult as they usually do not
leave behind physical traces of their existence. However, a family of viruses called retroviruses is a
notable exception to this rule.
Retroviruses have a step in their life cycle in which their genetic material is integrated into the
genome (the name for an organism’s complete set of genetic material) of the cell that they have
infected. In rare cases, when that cell is a precursor of a sperm or egg cell, then the viral genes may
then be passed on to the animal’s offspring, ultimately leaving genetic traces that can be studied in
modern animals. This acts as a genetic ‘fossil record’ of extinct viruses.
HERV-T was a retrovirus that spread among our primate ancestors for about 25 million years
before its extinction roughly 11 million years ago. Blanco-Melo et al. have now analyzed the genetic
remains left by HERV-T in the genomes of humans and related primates, and were able to use this
information to recreate a protein that made up the outer envelope that surrounded the virus.
Further experiments showed that this viral protein helped HERV-T to infect human cells by
interacting with a protein called MCT1 on the cell surface.
Blanco-Melo et al. also found a particular HERV-T gene that was unexpectedly well preserved in
the human genome. The gene retained its ability to produce an envelope protein for about 13 to 19
million years. It is likely that ancient primates ‘hijacked’ the viral gene and used the protein it
produced to remove the MCT1 protein from the surface of their own cells. Without MCT1 on the
surface, HERV-T was unable to infect the cells. Thus, these findings present an example of how
viruses themselves can provide the genetic material that animals use to combat them, potentially
leading to their extinction.
DOI: 10.7554/eLife.22519.002
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ensuing 25 MY, with the most recent integrations that became fixed in primates having
occurred ~11 MYA in hominids and ~8 MYA in macaques (Figure 1—source data 1).
Comparison of recovered HERV-T fossils indicated that the HERV-T2 clade derives from a single,
hypermutated HERV-T1 element (Figure 1—figure supplement 1B), and likely expanded by comple-
mentation in-trans. HERV-T3 represented the oldest HERV-T clade in catarrhini primates, with inte-
gration dates ranging from ~8 to ~30 MYA, and had the highest overall copy number (Figure 1A and
Figure 1—source data 1). There was some support for the division of HERV-T3 into two sub-clades
(Figure 1—figure supplement 1A). Using a maximum likelihood approach we inferred the sequence
of an infectious ancestral HERV-T3 from near complete proviruses (Figure 1A and Figure 1—source
data 1). Unlike fossilized viral elements, the reconstructed ancestral sequence had gag, pol and env
genes with full coding potential, and revealed the likely presence of an additional open reading
frame (ORF) of unknown function, located 5’ to gag (Figure 1B and Figure 1—figure supplement
2). We tested the functionality of the reconstructed ancestral HERV-T envelope gene (ancHTenv,
Figure 1. Functional reconstruction of a ~32 MY old HERV-T envelope protein. (A) Phylogenetic tree of HERV-T3 proviral sequences in OWM and apes.
Orthologous sequences are bracketed and estimated integration times indicated. * >90% bootstrap support. Red circle = ancestral root node. (B)
Ancestral HERV-T3 genome with ORFs indicated. (C) Infectivity of MLV particles containing a GFP reporter and pseudotyped with the ancHTenv protein
(Mean ± SD, n = 3 replicates). See also Figure 1—figure supplements 1–2.
DOI: 10.7554/eLife.22519.003
The following source data and figure supplements are available for figure 1:
Source data 1. HERV-T elements in OWM and ape genomes.
DOI: 10.7554/eLife.22519.004
Figure supplement 1. HERV-T proviruses cluster into four monophyletic clades.
DOI: 10.7554/eLife.22519.005
Figure supplement 2. Deduced sequence of a 32MY old ancestral HERV-T3.
DOI: 10.7554/eLife.22519.006
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Supplementary file 1) by generating murine leukemia virus (MLV) particles containing a gfp reporter
vector and pseudotyped with ancHTenv. MLV-ancHTenv virions were able to infect many cell lines at
high titer (105–106 infectious units (IU)/ml, Figure 1C) while some rodent (NIH3T3 and Rat2) and
chicken (DF-1) cells were comparatively resistant to MLV-ancHTenv (titers  103 IU/ml).
When challenged with an MLV-ancHTenv expressing a neo resistant gene, even DF-1 and NIH3T3
cells could be infected at low efficiency (titers of ~4  102 and ~1  103 G418-resistant colonies
(G418-RC)/ml). Therefore, DF-1 cells, which exhibited the lowest susceptibility to MLV-ancHTenv,
were selected to identify candidate HERV-T receptors as they would give the lowest ‘background’
level of infection in the context of a cDNA library screen. We generated a lentivirus-based human
cDNA library from human 293T cells, which were among the most highly permissive cell lines tested,
and then iteratively challenged and selected library-transduced DF-1 cells with MLV-ancHTenv virions
Figure 2. MCT-1 functions as a receptor for ancestral HERV-T. (A) Scheme of the receptor screening strategy. DF-1 cells were transduced with a
lentiviral cDNA library. Two days later, the cells were challenged with MLV-ancHTenv containing a neo gene. After a further two days, cells were placed
in G418 selection. After another 10 days, G418-resistant cells were replated and challenged with MLV-ancHTenv containing a hygromycin resistance
gene. Two days later cells were placed in hygromycin selection. After a further 10 days, Hygromycin-resistant cells were replated and challenged with
MLV-ancHTenv containing RFP and were found to be highly susceptible to infection (Figure 2—figure supplement 1A). Genomic DNA (gDNA) was
extracted from this cell population and subjected to PCR using primers specific to the lentiviral vector (Figure 2—figure supplement 1B). (B)
Fluorescent micrographs of 293T and DF-1 cells, expressing hMCT1 or a control protein, following infection with MLV-ancHTenv expressing GFP as
reporter. Scale bar = 200 mm. (C) Titers of MLV-ancHTenv/GFP on 293T and DF-1 cells expressing hMCT1 or a control protein (Mean ± SD, n = 2
replicates, one of two separate experiments).
DOI: 10.7554/eLife.22519.007
The following figure supplement is available for figure 2:
Figure supplement 1. HERV-T receptor identification.
DOI: 10.7554/eLife.22519.008
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containing antibiotic resistance or fluorescent protein genes (Figure 2A). This procedure progres-
sively enriched MLV-ancHTenv-susceptible DF-1 cells (Figure 2—figure supplement 1A). Lentiviral-
vector directed PCR primers were then used to identify a human cDNA in the selected cells, that
encoded human monocarboxylate transporter 1 (hMCT1, also known as SLC16A1, Figure 2—figure
supplement 1B), a 12-pass transmembrane protein that mediates the transport of monocarboxylates
such as lactate and pyruvate across the plasma membrane, and is upregulated in some cancers (Hale-
strap, 2012, 2013). Reintroduction of an hMCT1 cDNA into naı¨ve DF-1 cells rendered them highly
sensitive to infection with MLV-ancHTenv (Figure 2B and C). Moreover, MCT1 expression in DF-1
cells also conferred dramatically enhanced ability to bind to MLV Gag-GFP virus-like particles (VLPs)
pseudotyped with ancHTenv, but had no effect on the low-level binding of VLPs that lacked an Env
protein or incorporated an ecotropic MLV envelope (Figure 3). Thus, MCT1 was likely the receptor
used by HERV-T to infect ancient old world primates.
Notably, the modern human genome harbors a single HERV-T provirus that includes an env gene
with nearly full coding potential (de Parseval et al., 2003). This env ORF lacks only five amino acids
at the C-terminus, shares 86% amino acid identity with the reconstructed ancHTenv and is expressed
mainly in healthy thyroid tissue (de Parseval et al., 2003). The provirus is also present at the ortholo-
gous site in gorilla and orangutan genomes, but absent in chimpanzees due to a segmental deletion
at that locus. This provirus originated from bona-fide retroviral integration (presence of a 4 bp target
site duplication) into the internal sequence of another HERV (Repbase: HERVIP10FH), in a locus sur-
rounded by other repetitive sequence elements. Sequence similarity searches using the env region
suggested the absence of an orthologous insertion in non-hominid primate genomes. Moreover, the
divergence between the paired LTRs of this provirus gave an estimated integration date of ~7–19
MYA (Table 1). Adjustment of this estimate to account for species distribution leads to the conclu-
sion that this provirus was inserted into the germline of the ancestor of modern hominids at
least ~13–19 MYA.
Unlike the reconstructed ancHTenv, the Env protein product of the modern human HERV-T provi-
rus (hsaHTenv) was not able to generate infectious pseudotyped MLV particles (Figure 4A). More-
over, unlike ancHTenv-HA, the hsaHTenv-HA protein was not correctly processed and was not
incorporated into viral particles (Figure 4B). Furthermore, while ancHTenv expression was able to
drive syncytium formation, hsaHTenv had no fusogenic activity (Figure 4C and D). Inspection of the
hsaHTenv and orthologous env sequences in gorillas and orangutans revealed mutations at the site
where proteolytic cleavage by furin-like proteases generates surface (SU) and transmembrane (TM)
subunits (Hallenberger et al., 1992) (Figure 4E). Insertion of these cleavage site mutations into
ancHTenv abolished cleavage and pseudotype infection, while reversion of mutations in hsaHTenv
did not correct the cleavage defect and did not yield infectious MLV particles (Figure 4—figure sup-
plement 1), Thus, loss of HERV-T envelope function by hsaHTenv was a multi-step process, including
loss of furin cleavability, similar to findings with feline endogenous retroviral Env proteins (Ito et al.,
2016).
Although the hsaHTenv did not maintain function, it has retained a complete open reading frame
(ORF) since its deposition in an ancestral hominid genome. To determine the degree to which this
ORF preservation should be expected, we deduced an ancestral env gene sequence for this particu-
lar hominid provirus (ancHTenv16MYA) and simulated its neutral evolution using the human neutral
substitution rate (Lander et al., 2001). Only 6% of sequences maintained the env ORF following sim-
ulated neutral evolution for 13–19 MY (Figure 5A). Note that 6% represents an overestimate as
indels were not simulated. Strikingly, inspection of orthologous human and orangutan proviruses
revealed highly selective preservation of the env ORF, while numerous stop codons (6 to 16) and fra-
meshifts (3 to 5) were present in gag and pol genes of the same provirus (Figure 5B and Table 2).
For the gorilla provirus, a single nucleotide frameshift was the only lesion in env, suggesting recent
inactivation. Pairwise sequence comparisons revealed that the human and orangutan env genes
show signatures of purifying selection (dN/dS » 0.5, p<0.01), whereas comparisons with the gorilla
env suggest a relaxed selection (Table 1). Overall, selective pressures appear to have preserved this
HERV-T env ORF despite the loss of its retroviral envelope function, and numerous inactivating
mutations in the accompanying gag and pol genes.
We tested the antiviral potential of the hsaHTenv and its direct ancestor in hominids
(ancHTenv16MYA, Supplementary file 1) by expressing them into 293T cells, as well as DF-1 clones
expressing hMCT1-HA (Figure 6A). Strikingly, hsaHTenv and ancHTenv16MYA inhibited MLV-
Blanco-Melo et al. eLife 2017;6:e22519. DOI: 10.7554/eLife.22519 5 of 19
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Figure 3. Binding of ancHTenv-pseudotyped MLV particles to DF1 cells expressing MCT1. (A) Fluorescent
micrographs of MLV Gag-GFP VLPs pseudotyped with ancHTenv or ecotropic MLV, bound to DF-1 cells
expressing hMCT1 or an empty vector. Scale bar = 5 mm. (B) Enumeration of MLV Gag-GFP VLPs bearing the
Figure 3 continued on next page
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ancHTenv infection by >10 fold in both cell lines (Figure 6B and C and Figure 6—figure supple-
ment 1). Cell clones (293T) stably expressing hsaHTenv were ~50–100-fold less susceptible to MLV-
ancHTenv as compared to control cells, but fully susceptible to amphotropic MLV infection
(Figure 6D). Western blot analyses showed that hsaHTenv, ancHTenv16MYA or ancHTenv expression
caused depletion of endogenous MCT1 in 293T cells (Figure 7A). In DF-1 cells, expression of hsaH-
Tenv-HA, ancHTenv-HA or ancHTenv16MYA-HA clearly depleted Flag-tagged hMCT1 from the sur-
face of nearly all cells examined (Figure 7B and Figure 7—figure supplement 1). In the majority of
hsaHTenv-HA, ancHTenv-HA or ancHTenv16MYA-HA expressing DF-1 cells, MCT1-FLAG immunofluo-
rescence was nearly undetectable while a few cells showed low levels of intracellular staining (a mix-
ture of diffuse and punctate MCT1-FLAG staining) (Figure 7—figure supplement 1). Thus, these
data collectively suggest that ancHTenv16MYA and hsaHTenv exhibit antiviral activity specifically
against HERV-T by causing a reduction in the levels of MCT1 at the cell surface.
Discussion
These findings suggest a scenario in which HERV-T began to infiltrate primate germ lines, using
MCT1 as a receptor ~43–32 MYA. Later, ~19–13 MYA, a HERV-T Env sequence (represented approx-
imately by ancHTenv16MYA) was exapted by ancestral hominids and to serve as an antiviral gene.
AncHTenv16MYA apparently functioned by interacting with MCT1, either at the cell surface promoting
its internalization, or in the secretory pathway, blocking its transport to the plasma membrane, lead-
ing to MCT1 degradation and its depletion from the cell surface. This process is analogous to the
specific receptor interference phenomena observed in retroviral infections (Nethe et al., 2005) and
exploited by endogenous env genes that exhibit antiviral activity in other species (Gardner et al.,
1991; Ito et al., 2013; Kozak, 2015; Robinson and Lamoreux, 1976; Spencer et al., 2003).
Given the fusogenic potential of ancHTenv, it is likely that the progenitor of hsaHTenv
would have imposed a fitness cost on its ancestral hominid host. We speculate that the progenitor
of hsaHTenv acquired mutations either concurrent with, or after, its integration that resulted in loss
Figure 3 continued
indicated Env proteins bound to DF-1 cells expressing MCT-1 or an empty vector. Each data point represents an
individual cell (n = 20 for each condition).
DOI: 10.7554/eLife.22519.009
Table 1. Molecular evolution analyses of the provirus containing hsaHTenv in its orthologs. (1) Diver-
gence measured in substitutions per site. (2) Integration dates inferred from the divergence of the
paired LTRs for human, gorilla and orangutan proviruses. Age is calculated assuming a human neutral
substitution rate of 2.2  10 9 substitutions per site per year. (3) Pairwise dN/dS ratios for the env
genes calculated using codeml (CodonFreq = F3  4, Kappa and Omega estimated). (**) Significantly
different from dN/dS = 1 (p<0.01).
Locus LTR divergence(1) Age (MY)(2)
Env dN/dS ratio(3)
Gorilla Orangutan
Human 0.0317 7.20 1.4860 0.5184**
Gorilla 0.0414 9.41   0.7592
Orangutan 0.0855 19.43 0.7592  
DOI: 10.7554/eLife.22519.010
Source data 1. Likelihood ratio tests on dN/dS estimates for hsaHTenv and its orthologs. dN/dS ratios (w) were
estimated on a pairwise basis using codeml. Likelihood ratio tests were performed comparing the log likelihood of
the estimated w (L1) to the log likelihood when w was fixed to 1 (L0, neutral selection). The probability (P) of twice
the difference (D = 2(L1 L0)) was calculated using a chi-squared distribution (degrees of freedom = 1). The single
nucleotide frame-shift insertion in the gorilla sequence was artificially deleted in order to compare orthologous
codons.
DOI: 10.7554/eLife.22519.011
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Figure 4. The human genome encodes a HERV-T Env ORF that does not function as a retroviral envelope. (A) Infectiousness of MLV particles
pseudotyped with untagged or C-terminally HA-tagged ancHTenv or hsaHTenv (Mean ± SD, n = 3 replicates, one of two experiments). (B) Western blot
analyses (a-CA and a-HA) of cell lysates and MLV virions generated following expression of C-terminally HA-tagged ancHTenv or hsaHTenv M: markers.
(C) Examples of cell fusion in 293T cell cultures expressing ancHTenv or hsaHTenv linked to IRES-GFP. Scale bar = 100 mm. (D) Percentage of GFP+
multinucleated cells (>5 nuclei/cell) in 293T cell cultures expressing ancHTenv or hsaHTenv linked to IRES-GFP (Mean ± SD, n = 3 groups of ten
microscopic fields, one of two experiments) Blue: DAPI. (E) Alignment of ancHTenv and intact or nearly intact HERV-T Env protein sequences encoded
by hominid genomes, proximal to the furin cleavage site. See also Figure 4—figure supplement 1.
DOI: 10.7554/eLife.22519.012
The following figure supplement is available for figure 4:
Figure supplement 1. Effects of mutations at the furin cleavage site on ancHTenv and hsaHTenv processing.
DOI: 10.7554/eLife.22519.013
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of its fusogenic potential (e.g. furin cleavage site mutations). This sequence (represented approxi-
mately by ancHTenv16MYA) retained full length open reading frame and MCT1 binding activity, and
became fixed in the ancestral hominid population. Indeed, it is plausible that this exapted gene
might have contributed to the apparent extinction of HERV-T from hominids at some point after the
deposition of the most recent fixed hominid germline insertion, ~11 MYA.
The selection pressures acting on hsaHTenv, its orthologs and progenitors might have been com-
plex. Loss of fusogenicity but retention of receptor binding activity are, in a sense, opposing influen-
ces in terms of maintenance of the ORF and its function. Moreover, although some purifying
selective pressure (low dN/dS) can be detected in hsaHTenv and its orangutan ortholog, a relaxation
of those forces might be expected to have occurred after HERV-T extinction, perhaps leading to
reduced antiviral activity observed in modern hsaHTenv. Finally, as MCT-1 is a moncaboxylate trans-
porter that is upregulated in human cancers (Halestrap, 2013), the ability of hsaHTenv to deplete
MCT1 from cell surfaces may suggest an additional or alternative metabolism-related cellular or
Figure 5. Preservation of hsaHTenv and its orthologs in hominids. (A) Monte-Carlo simulations of ancHTenv16MYA evolution for 13.45–19.68 MY using a
human neutral substitution rate. The percentage of 10,000 simulated sequences of each type is plotted with error bars indicating maximum and
minimum estimates. (B) Distribution of stop codons (colored circles) in the Gag, Pol and Env coding sequence of proviruses orthologous to the HERV-T
provirus containing hsaHTenv.
DOI: 10.7554/eLife.22519.014
Table 2. Analysis of inactivating mutations of hsaHTenv encoding provirus in human, gorilla and
orangutan genomes. Proviral sequences were aligned to the ancestral HERV-T3 sequence. Nonsense
mutations and frameshift indels relative to the ancestral sequence were quantified. ‘Indel’ = insertion
or deletion events compared to the ancestral HERV-T3 sequence that resulted in a reading frame
change. ‘Stop’ = mutations that resulted in a stop codon. (*) Indicates a single nucleotide insertion








Indel Stop Indel Stop Indel Stop
Human 4 6 3 16 (1*) 0
Gorilla 4 6 4 15 1 (1*) 0
Orangutan 5 9 3 15 (1*) 0
DOI: 10.7554/eLife.22519.015
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Figure 6. The hsaHTenv protein specifically inhibits HERV-T infection. (A) Scheme of the antiviral assay. Cells, 293T or DF-1 expressing hMCT1, were
transduced with lentiviral vectors expressing HERV-T Env proteins or an unrelated protein (No Env) together with a GFP reporter gene to monitor
expression. Cells were challenged with MLV particles pseudotyped with ancHTenv that expresses RFP upon infection. Cell populations were analyzed
by FACS 2 days after infection. (B) Representative experiment based on the scheme depicted in (A) conducted using 293T cells expressing the
indicated Env proteins. (C) Infectivity of MLV-ancHTenv on 293T cells or two clones of MCT1-expressing DF1 cells (#14, #17), expressing HERV-T
envelope proteins according to the scheme described in (A). Plots describe the percentage of RFP positive cells (infected) after gating on the GFP
positive (Env-expressing) cell population. (Mean ± SD, n = 3 independent experiments). (D) Susceptibility of clones of 293T cells expressing an empty
vector or hsaHTenv-HA to infection by MLV-ancHTenv/GFP or amphotropic MLV/GFP (Mean ± SD, n = 3 three independent single cell clones assayed
once each). See also Figure 6—figure supplement 1.
DOI: 10.7554/eLife.22519.016
The following figure supplement is available for figure 6:
Figure supplement 1. Antiviral activity of HERV-T Env proteins.
DOI: 10.7554/eLife.22519.017
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even anti-tumor functions and selective pressures. Such an activity might have continued to shape
hsaHTenv sequence independent of anti-HERV-T activity. In either case, this study highlights the
potential importance of ERV proteins as raw material for the innovation of new functions in
human ancestors.
Materials and methods
Identification of HERV-T elements in primate genomes
Screening for HERV-T elements was performed using a BLAST-based strategy implemented using the
Database-Integrated Genome Screening (DIGS) tool (http://giffordlabcvr.github.io/DIGS-tool/). A
HERV-T genome consensus sequence (HERV-Tcons, constructed from previously identified HERV-T
sequences [Be´nit et al., 2001]) was used as query to mine old world monkey (OWM) and ape
genomes. Specifically, amino-acid and nucleotide sequences of the consensus HERV-T genome were
used as probes for tBLASTn (RRID: SCR_011822) (gag, pol and env) and BLASTn (RRID: SCR_001598)
(LTR) searches of a genome target database containing complete and low coverage primate genome
sequences that were retrieved from publicly available databases: Human (GenBank:
GCF_000002125.1), chimpanzee (GenBank: GCF_000001515.6), bonobo (GenBank:
GCA_000258655.2), gorilla (GenBank: GCA_000151905.1), orangutan (GenBank: GCF_000001545.4),
gibbon (GenBank: GCA_000146795.1), baboon (UCSC: papHam1), and rhesus macaque (GenBank:
GCA_000002255.2).
Figure 7. The hsaHTenv protein causes depletion of hMCT1 from the cell surface. (A) Western blot analyses (a-HA, a-hMCT1 and a-hHsp90) of 293T
cell lysates generated following transduction with lentiviral vectors encoding C-terminally HA-tagged HERV-T envelopes. (B) Immunofluorescent
micrographs of hMCT1-Flag-expressing DF-1 cells transduced with vectors expressing hsaHTenv-HA or an empty vector. Green: a-Flag, red: a-HA,
Blue: DAPI. Scale bar = 5 mm. See also Figure 7—figure supplement 1.
DOI: 10.7554/eLife.22519.018
The following figure supplement is available for figure 7:
Figure supplement 1. Additional examples of MCT-1 depletion and releocalization following expression of HERV-T Env proteins.
DOI: 10.7554/eLife.22519.019
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To avoid the identification of sequences from related but distinct retroviruses, significant BLAST
hits (e-value < 1E-50) were used as probes for a second round of BLASTx (RRID: SCR_001653) (trans-
lated coding hits) or BLASTn (non-coding hits) searches against a sequence reference library contain-
ing exogenous and endogenous gammaretroviruses and other class-I ERVs (including HERV-Tcons).
Exogenous retroviral sequences were retrieved from the RefSeq database (RRID: SCR_003496)
(Pruitt et al., 2014), and ERV sequences were based either on consensus sequences of previously
published ERV sequence data (Be´nit et al., 2001; Sverdlov, 2005; Tristem, 2000; Villesen et al.,
2004), or previously inferred consensus sequences (Jern et al., 2005).
BLAST hits assigned to HERV-T were first ordered by genome scaffold and orientation, and adja-
cent or overlapping entries were assembled into proviral loci by comparison with HERV-Tcons, allow-
ing for insertions no longer than 10,000 nt.
Phylogenetic analyses
Due to the high numbers of mutations, especially indels, accumulated in ERV sequences, 44 nearly-
complete HERV-T sequences were aligned to HERV-Tcons using MUSCLE (RRID: SCR_011812)
(Edgar, 2004) in a pair-wise fashion, followed by the creation of a ‘gapped’ multiple sequence align-
ment (MSA) using the profile alignment function. Insertions relative to HERV-Tcons were removed
from the MSA, but saved in a separate file allowing for the restoration of the removed insertions if
required.
Maximum likelihood (ML) phylogenetic trees were constructed from a nucleotide MSA (described
above) using raxML (RRID: SCR_006086) (Stamatakis, 2006) with the following parameters: rapid
bootstrap analysis with 1000 replicates under the GTRCAT model followed by a ML search under
GTRGAMMA model to evaluate the final tree topology (-m GTRCAT -# 1000 -x 13 k -f a). Phyloge-
netic trees were then analyzed using FigTree v1.4.2 (RRID: SCR_008515) (Rambaut, 2008). Thereaf-
ter, the tree was rooted using a platyrrhini HERV-T-like sequence as outgroup. The resulting tree
showed three monophyletic HERV-T clades (corresponding to HERV-T1, HERV-T2 and HERV-T3 in
old world primates) whose LTR sequences were clearly distinct. Consensus sequences were derived
from each clade and used to re-classify the results from the primate genome screening.
Molecular evolution analyses of HERV-T proviruses
Dates of integration for HERV-T elements were calculated using PAUP* (RRID: SCR_014931) (Swof-
ford, 2002) by determining the divergence (K) from: (i) the corresponding consensus sequence (for
soloLTRs), or (ii) to their cognate LTR (for proviral loci flanked by paired LTRs). The resulting K was
divided by two times the neutral substitution rate (r) in order to obtain the estimated integration
date (K/2r) (Lebedev et al., 2000; Subramanian et al., 2011). The human neutral substitution rate
used was 2.2  10 9 substitutions per site per year (Lander et al., 2001).
APOBEC3-derived hypermutation analysis and statistics were performed using Hypermut 2.0
(RRID: SCR_014933) (Rose and Korber, 2000) on 49 gag-pol-env HERV-T containing sequences in
OWM and ape genomes using default parameters. HERV-T sequences with p-value<0.05 in a Fisher
exact-test, were treated as significant for APOBEC3- derived hypermutation.
dN/dS (w) ratios were calculated on a pairwise basis, by comparing the aligned codon sequences
of the human, gorilla (after artificially removing a 1nt frame-shift insertion) and orangutan env genes,
using codeml from the PAML package of programs (RRID: SCR_014932) (Yang, 1997) (runmode =
 2, CodonFreq = F3  4, Kappa and Omega estimated). Likelihood ratio tests were performed by
comparing the log likelihood of the estimated w (L1) to the log likelihood when w was fixed to 1 (L0,
neutral selection). The probability (P) of twice the difference (D = 2(L1 L0)) was calculated using a
chi-squared distribution (degrees of freedom = 1).
Ancestral sequence reconstructions
For the ancestral reconstruction of HERV-T3, we first analyzed the 5’ and 3’ flanking sequences of 22
near complete HERV-T3 proviruses retrieved from old world monkey and ape genomes. These analy-
ses resulted in fourteen unique HERV-T3 integration events (orthologous groups). Ancestral nodes
for each orthologous group were used for the ancestral reconstruction.
Initial ML ancestral reconstructions were guided by a MSA together with a phylogenetic tree
using baseml (PAML (RRID: SCR_014932) (Yang, 1997), model: REV, branch lengths were used as
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initial values). Initial values of alpha and kappa were calculated on the MSA by jmodeltest
(Darriba et al., 2012). A correction for the effect of methylation-induced mutations at CpG dinucleo-
tides was applied on both strands of all ancestral reconstructed sequences as previously described
(Goldstone et al., 2010).
The resulting ancestral HERV-T3 sequence was further refined in two locations. A single nucleo-
tide insertion, relative to the ancestral HERV-T1 sequence, was eliminated in the 5’ pre-gag ORF
resulting in the suppression of a frame-shift mutation and an expansion of 43 codons relative to the
original ancestral HERV-T3 sequence. Additionally, the state of particularly polymorphic si tes in the
pre-gag ORF was hand curated by a combination of their frequency and the phylogenetic relation-
ships between the corresponding HERV-T3 sequences. The variation present in HERV-T1 sequences
was used to break possible ties. A similar procedure was performed on the initial HERV-T3 ancestral
env sequence with the additional consideration that if the CpG reversion procedure, at a particular
position, resulted in the change in chemical nature of the amino acid, the residue at this position
was reverted to its ‘pre-CpG reversion’ state. The final revised sequence corresponded to ancHTenv
(Supplementary file 1).
The ancestral reconstruction for ancHTenv16MYA (Supplementary file 1) was performed manually
by selecting residues based on the phylogenetic relationships of the three Env sequences present in
human, gorilla and orangutan. Polymorphic sites were resolved by comparison with the ancHTenv
sequence.
Identification of hsaHTenv orthologs
Characterization of the hsaHTenv orthologs in other primate species and the ~196 Kb segmental
deletion in the Chimpanzee genome, was done using the UCSC genome browser (RRID: SCR_
005780) (Kent et al., 2002) and tools implemented therein. Stop codon analysis was performed by
translating the proviral sequences in all three forward reading frames and the location of their stop
codons was plotted using R (RRID: SCR_001905). Frameshift mutations were identified by aligning
proviral sequences to the ancestral HERV-T3 sequence.
In silico simulation of neutral evolution
Monte-Carlo simulations of in silico neutral evolution on the ancHTenv16MYA were performed using
seq-gen (RRID: SCR_014934) (Rambaut and Grassly, 1997) under the GTR model (10,000 iterations)
as previously described (Katzourakis and Gifford, 2010). Expected branch lengths were calculated
for the minimum and maximum estimates of the origin of hominids (13.45 and 19.68 MY respec-
tively) (Perelman et al., 2011) using the neutral substitution for humans. The simulated 10,000
sequences were then evaluated for the presence of a 5’ methionine and premature stop codons.
Analysis of HERV-T Env protein sequences
Analysis for the features of HERV-T envelope sequences was performed using tmhmm 2.0 (RRID:
SCR_014935) (Krogh et al., 2001) for transmembrane and hydrophobic domains, and ProP1.0
(RRID: SCR_014936) (Duckert et al., 2004) for signal peptide and propeptide cleavage sites.
Plasmid construction
The codon-optimized sequences for expression in human cells of ancHTenv, hsaHTenv (GenBank:
AB266802) and ancHTenv16MYA were synthesized (Genewiz, South Plainfield, NJ) and subsequently
inserted into the pCAGGS expression vector (Niwa et al., 1991) using EcoRI and XhoI (NEB, Ips-
wich, MA) restriction enzymes.
Furin cleavage site modified HERV-T envelopes were generated by exchanging the furin cleave-
age sites of ancHTenv and hsaHTenv, and vice versa. Specifically, mutagenic PCR primers that
annealed to sequences encoding the respective furin cleavage sites were used in overlapping PCR
reactions, resulting in the generation of ancHTenv-FurinMut (SRFRRAA to PRLHQAV) or hsaHTenv-
FurinFix (PRLHQAV to SRFRRAA). The PCR reactions were treated with DpnI (NEB, Ipswich, MA)
restriction enzyme for an hour at 37˚C to eliminate plasmid DNA. The complete PCR fragment was
inserted into pCAGGS using EcoRI and XhoI restriction sites encoded in the outer primers.
HA-tagged HTenv expression plasmids were generated by introducing two copies of an HA-tag
at the C-termini of all HERV-T envelopes using PCR and primers containing the tag DNA sequence
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and a 15nt linker sequence. The complete PCR fragments were inserted back into pCAGGS using
EcoRI and XhoI restriction sites contained in the PCR primers. HA-tagged HERV-T envelope con-
structs were also subcloned into pCCIB (a lentiviral expression vector containing a CMV-promoter
and IRES-blasticidin resistance cassette), using SfiI (NEB, Ipswich, MA) restriction sites contained in
the PCR primers, to generate stably-expressing cell lines and clones. HA-tagged HERV-T envelope
constructs or a control protein (GFP) were also subcloned into pCCIGW (lentiviral expression vector
containing a CMV-promoter and IRES-GFP), using SnaBI and BstXI (NEB, Ipswich, MA) restriction
sites contained in the PCR primers.
The sequence encoding human MCT1 (hMCT1, UniProt: P53985) was amplified from the gDNA
of DF-1 cells that had been transduced with a 293T cDNA library and selected as described below.
The amplified hMCT1 sequence was inserted into pCCIB utilizing SfiI sites, and the resulting vector
used to generate stable DF-1 cell lines expressing hMCT1. C-terminally HA-tagged or Flag-tagged
versions of hMCT1 were generated using PCR with primers containing two HA-tag or three Flag-tag
encoding sequences and a 15nt linker sequence. The complete PCR fragment was inserted back into
pCCIB using SfiI restriction sites contained in the PCR primers.
Cell culture
All cells were purchased from ATCC (Manassas, VA), except MT2 (RRID: CVCL_2631) and NIH3T3
(RRID: CVCL_0594) that were obtained through the NIH AIDS Reagent Program, and Huh7.5 (RRID:
CVCL_7927) that were a gift from Charles M Rice, where they were derived. Cells were assumed to
be authenticated by their respective suppliers and were not further characterized. Cells were main-
tained in Dulbecco’s Modified Eagle Medium (DMEM) (293T (RRID: CVCL_0063), DF-1 (RRID: CVCL_
0570), HT1080 (RRID: CVCL_0317), K562 (RRID: CVCL_0004), Huh7.5, FRhK4 (RRID: CVCL_4522),
MusDunni (RRID: CVCL_9125), NIH3T3 and Rat2 (RRID: CVCL_0513)), Eagle’s Minimum Essential
Medium (EMEM) (MRC5 (RRID: CVCL_0440), CV-1 (RRID: CVCL_0229), CRFK (RRID: CVCL_2426)
and MDCK (RRID: CVCL_0422)), Roswell Park Memorial Institute medium (RPMI) (MT2), or Ham’s
F-12 media (CHO (RRID: CVCL_0214)) supplemented with 10% FBS or BCS (NIH3T3), 1 mM of L-glu-
tamine (CHO) and gentamycin (2 mg/ml) (Gibco, Waltham, MA) according to ATCC instructions.
Mycoplasma testing was not specifically performed, but many cell lines were used in immunofluores-
cence assays with DAPI staining that should reveal presence of mycoplasma. All cells were incubated
at 37˚C except DF1 that were incubated at 39˚C.
To generate stable cell lines, 293T cells were transfected with plasmids expressing HIV-1 Gag-Pol
(pCRV1 [Zennou et al., 2004]), VSV glycoprotein and pCCIB plasmids encoding hMCT1 or HA-
tagged/untagged versions of HERV-T envelopes using polyethylenimine. In every case virus/vector
containing supernatants were harvested and filtered two days after transfection and were used to
transduce naı¨ve 293T or DF-1 cells. Transduced cells were expanded in 10 cm dishes with media sup-
plemented with 5 mg/ml (293T) or 20 mg/ml (DF-1) blasticidin S (Thermo Fisher Scientific Inc., Wal-
tham, MA) and were monitored from 3 to 10 days before performing experiments or isolating single
cell clones.
MLV pseudotype infectivity assays
MLV particles pseudotyped with MLV amphotropic (MLV-A) or ecotropic (MLV-E), and different
HERV-T envelopes were generated by co-transfecting 293T cells with (i) the corresponding envelope
plasmids, plasmids (ii) expressing MLV gag-pol polyprotein (MLVgp) and (iii) an MLV vector encoding
a neo gene and/or GFP/RFP (pCNCG/pCNCR) (Soneoka et al., 1995) using polyethylenimine.
Viruses were harvested and filtered (0.22 mm) two days after transfection. Viral stocks were concen-
trated using the Amicon Ultra-15 filters (10 kDa) (Millipore, Billerica, MA) before freezing. Cells of
interest were infected with serial dilutions of the corresponding virus supplemented with 4 mg/ml of
polybrene. Viral titers were calculated by measuring the percentage of infected cells expressing GFP
or RFP, 2 days post infection (dpi) using the Guava EasyCyte flow cytometer (Millipore). For MLV
particles expressing neo resistance genes, viral titers were calculated by expanding the infected cells
in 10 cm dishes with media supplemented with 1 mg/ml (NIH3T3) or 2 mg/ml (DF-1) of G418 and
monitoring for 10 days before resistant colonies were counted.
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cDNA library preparation and screening
Total RNA was isolated from a confluent 10 cm dish of 293T cells using Trizol (Invitrogen, Carlsbad,
CA). mRNA transcripts were enriched using Oligotex polyA+ resin (Qiagen, Hilden, Germany). Polya-
denylated RNA was used to construct a cDNA library using the SMART cDNA Library Construction
Kit (Clontech, Mountain View, CA). Briefly, cDNA containing SfiI restriction sites was synthesized
using the SMARTScribe MMLV reverse transcriptase (Clontech) with SMART primers. The resulting
cDNA was further amplified for 15 cycles using Phusion High-Fidelity DNA Polymerase (Thermo
Fisher Scientific Inc.) using SMART primers. PCR products were treated with Proteinase K (Clontech)
for 20 min at 45˚C before they were digested by SfiI restriction enzyme for 2 hr at 50˚C. Digested
cDNA was then size fractionated using CHROMA SPIN-400 columns (Clontech). The cDNA contain-
ing fractions (>500 bp) were selected to ligate into a pCCIB plasmid encoding corresponding SfiI
sites. Overnight ligation was performed using T4 DNA ligase (NEB) and the library was expanded by
transformation into electrocompetent DH5a bacteria cells. The 293T cDNA library had a complexity
of 3.5  106 colony forming units. Transformed bacteria were cultured as suspended colonies in 6 lit-
ers of SeaPrep soft agarose (Lonza, Basel, Switzerland) diluted in 2x LB media at 30˚C for 2.5 days.
Thereafter plasmid DNA was extracted and used for receptor cloning.
Lentiviral vector stocks carrying the cDNA library were produced by transfecting 6  106 293T
cells with plasmids expressing HIV-1 gag-pol polyprotein (pCRV1), VSV glycoprotein and the cDNA
library plasmid (pCCIB). Library containing supernatants were harvested, filtered (0.22 mm), concen-
trated (Amicon Ultra-15 filters 10 kDa, Millipore) and frozen two days after transfection. DF-1 cells
were transduced with the library at an MOI of ~8. Transduced DF-1 cells were then challenged with
MLV particles pseudotyped with ancHTenv and containing a neo resistance gene (pCNCG) two days
later. Infected DF-1 cells were placed in G418 selection at 2 dpi and resistant colonies were col-
lected after 10 days. G418 resistant DF-1 cells were then challenged with ancHTenv pseudotyped
MLV particles containing a hygromycin resistance gene (pLHCX). Cells were placed in hygromycin
selection at 2 dpi and resistant colonies were collected after 10 days. Hygromycin resistant DF-1 cells
were infected with ancHTenv pseudotyped MLV particles expressing RFP (pCNCR) and found to be
susceptible to infection. Genomic DNA (gDNA) was extracted from this DF-1 cell population and
possible receptor candidates were amplified using PCR and primers directed to the pCCIB vector
sequences flanking the SfiI cDNA insertion site. A non-coding isoform of human atg12 and
hMCT1 were amplified from gDNA of transduced and selected DF-1 cells. For all PCRs performed in
this study Phusion High-Fidelity DNA Polymerase was used.
Virus-like particle (VLP) binding assay
Fluorescent MLV VLPs were generated by co-transfecting 293T cells with a plasmid (pCAGGS)
expressing MLV Gag-GFP and a plasmid (pCAGGS) expressing ancHTenv, MLV-E or an empty vec-
tor, using polyethylenimine. VLPs were harvested and filtered (0.22 mm) two days after transfection
and concentrated using the Amicon Ultra-15 filters (10 kDa, Millipore). The VLP binding assay was
performed as previously described (Soll et al., 2010) using naı¨ve DF-1 cells or a DF-1 clone express-
ing untagged hMCT1. Fluorescent microscopy images of the cells were acquired using a DeltaVision
deconvolution microscope (GE Healthcare, Port Washington, NY). A Z-series of images (capturing
the entire thickness of the cell monolayer) were flattened onto a single image and the number of
fluorescent particles associated with each cell was counted for 20 distinct cells.
To determine the number of fluorescent VLPs added to the cells, 80 ml of the VLP-containing
supernatant was was layered onto 1 ml of 20% sucrose in PBS followed by centrifugation at 20,000 x
g for 90 min at 4˚C. Pelleted VLPs were resuspended in 300 ml of PBS and filtered (0.22 mm). Two-
fold serial dilutions of the VLPs (in PBS) were layered (100 ml) to poly-D-lysine coated glass coverslips
and left overnight at 4˚C. Fluorescent microscopy images of the VLPs were analyzed using the Delta-
Vision software (GE Healthcare) to determine the number of VLPs/ml for each condition. The number
of fluorescent particles bound to cells was then calculated as a proportion of the number of fluores-
cent VLPs added to the cells.
Western blot assays
Cell lysates and pelleted virions (600 ml of supernatant pelleted through 20% sucrose in PBS) were
resuspended in SDS-PAGE loading buffer, with the addition of 0.5% b-mercaptoethanol, and
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resolved on NuPAGE Novex 4–12% Bis-Tris Mini Gels (Invitrogen) in MOPS running buffer. Proteins
were blotted onto nitrocellulose membranes (HyBond, GE-Healthcare) in transfer buffer (25 mM Tris,
192 mM glycine). The blots were then blocked with Odyssey blocking buffer and probed with rat
monoclonal anti-MLV capsid (RRID: CVCL_9230, ATCC, R187), rabbit polyclonal anti-HA (RRID: AB_
217929, Rockland Immunochemicals, Pottstown, PA, 600-401-384), mouse monoclonal anti-HA
(RRID: AB_2314672, Covance, Princeton, NJ, MMS-101P), mouse monoclonal anti-hMCT1 (RRID:
AB_10841766, Santa Cruz Biotechnology Inc., CA, sc-365501), rabbit polyclonal anti-hHsp90 (RRID:
AB_2121191, Santa Cruz Biotechnology Inc., CA, sc-69703) or mouse monoclonal anti-Flag (RRID:
AB_262044, Sigma-Aldrich, St. Louis, MO, F1804). The bound primary antibodies were detected
using a fluorescently labeled secondary antibody (IRDye 800CW or 680W Goat Anti-Mouse or anti-
Rabbit Secondary Antibody, LI-COR Biosciences, Lincoln, NE, RRIDs: AB_621842, AB_621840,
AB_10796098, AB_621841). Fluorescent signals were detected using a LI-COR Odyssey scanner (LI-
COR Biosciences).
Immunofluorescence assays
Stable cell populations or single cells clones expressing a particular HA-tagged HERV-T envelope
and/or Flag-tagged/untagged hMCT-1 were seeded one day prior to immunofluorescence assay.
Cells were fixed with 4% PFA for 30 min followed by treatment with 10 mM glycine (diluted in PBS)
for another 30 min. Cells were permeabilized with a PBS containing 0.1% Triton X-100% and 5%
goat serum for 15 min. Cells were then washed twice with PBS before being incubated with rabbit
anti-HA and mouse anti-Flag antibodies diluted in PBS containing 0.1% Tween-20% and 5% goat
serum for 2 hr at room temperature. Cells were washed three times with PBS before being treated
with goat anti-mouse and/or anti-rabbit secondary antibody (Alexa Fluor 488 and/or 594 dye, Life
technologies, CA, RRIDs: AB_2534091, AB_2534088, AB_2534095, AB_2576217) diluted in PBS con-
taining 0.1% Tween-20% and 5% goat serum for 1 hr at room temperature. DNA was stained with
50 mg/ml of DAPI (diluted in PBS) (Invitrogen) for 5 s. Cells were washed three more times with PBS
and fluorescent microscopy images were analyzed using the a DeltaVision microscope (GE Health-
care) or the EVOS FL Cell Imaging System (Thermo Fisher Scientific Inc.).
Assay for effects of HERV-T Env on infection
Viruses were generated in 293T cells transfected with plasmids expressing HIV-1 gag-pol polyprotein
(pCRV1), VSV glycoprotein and pCCIGW (IRES-GFP) plasmids and expressing the various HERV-T
envelopes described above, or an unrelated protein as control (SIVgab Nef) using polyethylenimine.
Viruses were harvested and filtered (0.22 mm) two days after transfection and were used to transduce
2  105 naı¨ve 293T cells or 1  105 DF-1 clones expressing HA-tagged hMCT1. Transduced cells
were expanded in 10 cm dishes until reaching confluency. Afterwards, serial dilutions of MLV
expressing RFP (pCNCR) pseudotyped with ancHTenv were used to infect 1  104 transduced cells
in 96 well plates. Two days post infection the number of GFP+, RFP+ and double positive cells were
counted by FACS using a CyFlow space cytometer (Partec, Go¨rlitz, Germany). The resulting data
was analyzed with the FlowJo analysis software. The percentage of RFP positive cells was calculated
after gating on the GFP positive population.
Cell fusion analysis
293T cells were transduced with a lentivirus vector (CCIGW) expressing various HERV-T envelopes or
a control protein (SIVgab Nef) (described above) and then fixed and stained with DAPI (described
above). Multinucleated cells (>5 nuclei) and cells expressing the GFP reporter (indicative of the
expression of the corresponding HERV-T envelope) were counted in three groups of ten microscopic
fields and the number of multinucleated GFP+ cells as a percentage of the total number GFP+ cells
was calculated for each condition.
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